TP Therapeutics competitors

TP Therapeutics Competitors include CytomX Therapeutics, Merrimack Pharmaceuticals, TESARO and Infinity Pharmaceuticals.
Add company...
TP Therapeutics
TP Therapeutics
TP Therapeutics is a clinical-stage structure-based drug design company which discovers and develops precision medicines for cancer and other diseases.
CytomX Therapeutics
CytomX Therapeutics
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.
TESARO
TESARO
TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.
Infinity Pharmaceuticals
Infinity Pharmaceuticals
Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.
Founding Date
Founding Date
2013
Founding Date
2008
Founding Date
2000
Founding Date
2010
Founding Date
2000
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
San Diego, US HQ
Locations
South San Francisco, US HQ
Locations
Cambridge, US HQ
Locations
Waltham, US HQ
Locations
Cambridge, US HQ
Employees
Employees
31
Employees
92
Employees
294
Employees
446
Employees
22
Valuation ($)
Valuation ($)
N/A
Valuation ($)
838.9 m
Valuation ($)
78.2 m
Valuation ($)
4.1 b
Valuation ($)
79 m
Twitter followers
Twitter followers
29
Twitter followers
385
Twitter followers
1.1 k
Twitter followers
1.8 k
Twitter followers
1.8 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$71.6m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
$223.3m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
N/A
Net income
($43.1m) (FY, 2017)
Net income
$470.9m (FY, 2017)
Net income
($496.1m) (FY, 2017)
Net income
($41.8m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 144.4m
Total funding raised
$ 132.4m
Total funding raised
$ 79.4m
Total funding raised
$ 161m
Total funding raised
$ 178.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

CytomX Therapeutics
HQ
South San Francisco, US
Employees
92

CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.

View company
Merrimack Pharmaceuticals
HQ
Cambridge, US
Employees
294

Merrimack Pharmaceuticals discovers, designs and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer.

View company
TESARO
HQ
Waltham, US
Employees
446

TESARO is an oncology-focused biopharmaceutical company identifying better cancer therapies to improve the lives of patients with cancer.

View company
Infinity Pharmaceuticals
HQ
Cambridge, US
Employees
22

Infinity Pharmaceuticals engages in the discovery and development of medicines for the treatment of cancer and related conditions.

View company